Cancer, Ovarian Completed Phase 1 Trials for Bevacizumab (DB00112)

Also known as: Cancer of the Ovary / Ovarian Cancer / Ovary Cancer / Cancer of Ovary / Ca ovary / Malignant tumor of ovary / Malignant neoplasm of ovary / Ovarian cancer NOS

IndicationStatusPhase
DBCOND0063542 (Cancer, Ovarian)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01219777Neoadjuvant Chemotherapy IV Carboplatin With Weekly Paclitaxel \Bevacizumab for Primary OvarianTreatment
NCT01995188A Study to Evaluate the Safety and Pharmacology of DNIB0600A in Participants With Platinum-Sensitive Ovarian Cancer or Non-Squamous Non-small Cell Lung CancerTreatment
NCT00846612Pharmacokinetic Study of Avastin and Doxil in Ovarian CancerTreatment